Biogen Inc. (BIIB)
NASDAQ·Healthcare·Drug Manufacturers - General
$217.29
-0.80%
Mkt Cap $32.37B
Analyst Ratings
Buy
25
Hold
13
Sell
0
Price Target (146 analysts)
$245.88
Range $175.00 – $300.00
Implied Upside
+13.2%
Consensus $245.88 vs current $217.29